Literature DB >> 23279714

Field veterinary survey on clinical and economic impact of Schmallenberg virus in Belgium.

L Martinelle1, F Dal Pozzo, B Gauthier, N Kirschvink, C Saegerman.   

Abstract

We implemented a questionnaire-based methodology targeting veterinary field practitioners to evaluate clinical and economic impact of Schmallenberg virus in Belgium. First suspicious cases were detected as soon as July 2011. The mean cost for individual symptomatic treatment was 65 or 107 Euros, in case of fatal outcome or apparent recovery, respectively.
© 2012 Blackwell Verlag GmbH.

Entities:  

Keywords:  Schmallenberg virus; clinical signs; economical losses; emerging disease; impact evaluation; survey

Mesh：

Year:  2012        PMID： 23279714     DOI： 10.1111/tbed.12030

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN： 1865-1674            Impact factor:   5.005


  16 in total

Review 1.  Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe.

Authors:  Virginie Doceul; Estelle Lara; Corinne Sailleau; Guillaume Belbis; Jennifer Richardson; Emmanuel Bréard; Cyril Viarouge; Morgane Dominguez; Pascal Hendrikx; Didier Calavas; Alexandra Desprat; Jérôme Languille; Loïc Comtet; Philippe Pourquier; Jean-François Eléouët; Bernard Delmas; Philippe Marianneau; Damien Vitour; Stéphan Zientara
Journal:  Vet Res       Date:  2013-05-15       Impact factor: 3.683

2.  Productive and reproductive performances of dairy cattle herds in Treviso province, Italy (2009-2012): an assessment of the potential impact of Schmallenberg virus epidemic.

Authors:  Marica Toson; Lapo Mughini-Gras; Katia Capello; Laura Gagliazzo; Laura Bortolotti; Matteo Mazzucato; Stefano Marangon; Lebana Bonfanti
Journal:  BMC Vet Res       Date:  2015-08-11       Impact factor: 2.741

3.  Integration of production and financial models to analyse the financial impact of livestock diseases: a case study of Schmallenberg virus disease on British and French dairy farms.

Authors:  Barbara Häsler; Pablo Alarcon; Didier Raboisson; Agnes Waret-Szkuta; Jonathan Rushton
Journal:  Vet Rec Open       Date:  2015-04-01

4.  Application of integrated production and economic models to estimate the impact of Schmallenberg virus for various sheep production types in the UK and France.

Authors:  Pablo Alarcon; Barbara Häsler; Didier Raboisson; Agnes Waret-Szkuta; Fabien Corbière; Jonathan Rushton
Journal:  Vet Rec Open       Date:  2014-11-21

5.  Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection.

Authors:  Silke Hechinger; Kerstin Wernike; Martin Beer
Journal:  Vet Res       Date:  2013-12-05       Impact factor: 3.683

6.  Impact of Schmallenberg virus on British sheep farms during the 2011/2012 lambing season.

Authors:  K A Harris; R D Eglin; S Hayward; A Milnes; I Davies; A J C Cook; S H Downs
Journal:  Vet Rec       Date:  2014-05-02       Impact factor: 2.695

7.  Application of integrated production and economic models to estimate the impact of Schmallenberg virus for various beef suckler production systems in France and the United Kingdom.

Authors:  Didier Raboisson; Agnès Waret-Szkuta; Jonathan Rushton; Barbara Häsler; Pablo Alarcon
Journal:  BMC Vet Res       Date:  2014-10-26       Impact factor: 2.741

8.  Risk factors for malformations and impact on reproductive performance and mortality rates of Schmallenberg virus in sheep flocks in the Netherlands.

Authors:  Saskia Luttikholt; Anouk Veldhuis; René van den Brom; Lammert Moll; Karianne Lievaart-Peterson; Klaas Peperkamp; Gerdien van Schaik; Piet Vellema
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

9.  Single immunization with an inactivated vaccine protects sheep from Schmallenberg virus infection.

Authors:  Silke Hechinger; Kerstin Wernike; Martin Beer
Journal:  Vet Res       Date:  2014-08-03       Impact factor: 3.683

10.  Schmallenberg virus among female lambs, Belgium, 2012.

Authors:  François Claine; Damien Coupeau; Laetitia Wiggers; Benoît Muylkens; Nathalie Kirschvink
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.